|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/7042 | |
| A61K 9/24 | |||
| A61K 31/381 | |||
| A61K 9/20 | |||
| A61K 31/155 |
| (11) | Patento numeris | 2590631 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11736495.0 |
| Europos patento paraiškos padavimo data | 2011-07-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-05-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-10-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2011/042988 |
| Data | 2011-07-06 |
| (87) | Numeris | WO 2012/006298 |
| Data | 2012-01-12 |
| (30) | Numeris | Data | Šalis |
| 361543 P | 2010-07-06 | US |
| (72) |
DELAET, Urbain, Alfons Clementina, BE
FAURE, Anne, BE
HEYNS, Philip, Erna Hortentia Gilbert, BE
JANS, Eugeen, Maria Jozef, BE
RAILKAR, Aniruddha, US
|
| (73) |
Janssen Pharmaceutica NV,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (54) | FORMULATION FOR CO-THERAPY TREATMENT OF DIABETES |
| FORMULATION FOR CO-THERAPY TREATMENT OF DIABETES |